We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





World's Smallest POC Device for Complete Blood Count in 30 Minutes Unveiled

By LabMedica International staff writers
Posted on 26 Jul 2023

Hilab (Manaus, Brazil), a frontrunner in innovative healthcare solutions, is presenting its groundbreaking technologies at the AACC 2023. More...

Among the highlights are two pivotal launches and a unique point-of-care Hemogram device—the world's only instrument capable of providing a comprehensive blood count using artificial intelligence and other cutting-edge technologies within just 30 minutes.

The company’s pioneering device, the Hilab Lens, marks a substantial leap in digital microscopy. As the smallest point-of-care device that can perform a complete blood count, it operates by medical professionals collecting a fingertip blood sample, much like rapid glucose tests. The procured sample is housed in a capsule and fed into the device, where its information is then transmitted to the company's central laboratory via the Internet of Things. Initially, the sample is validated by artificial intelligence, followed by a specialized hematology healthcare professional. Within half an hour, the test results are dispatched to the patient through an SMS and email, an impressive feat considering traditional methods can take anywhere from 12 to 48 hours.

In addition, Hilab is introducing two more devices at the show—the Hilab Volt and the Hilab Wave. These compact devices will also be remotely connected to the health tech's central laboratory via the Internet. The Hilab Volt, which works on the principles of electrochemistry, reads an electrode that selectively interacts with the sample, generating an insightful analytical electrical signal. It can help evaluate parameters such as calcium, sodium, potassium, iron, and glucose, among others. The Hilab Wave, functioning via spectrophotometry—an optical analysis methodology used for quantitative measurement of light absorption by solutions—facilitates numerous tests, including those for phosphorus, magnesium, cholesterol, Vitamin D, and even for detecting Malaria.

“The complete blood count is so popular because it evaluates the quantity and quality of the main blood components, supporting the assessment and monitoring of acute infectious conditions, anemia evaluation, as well as assessing overall health,” said Bernardo Almeida, an infectious disease physician, and Chief Medical Officer of Hilab. “With the test's ease and speed, medical professionals and patients can benefit from the prompt delivery of results in both routine and emergency cases.”

“Participating in a scientific and international event of this magnitude reinforces Brazil's ability to transform the healthcare sector using technology as an ally,” added Marcus Figueredo, CEO, and co-founder of Hilab. “For Hilab, as a Brazilian company, this is a particularly special and rewarding moment, marking a positive milestone in their history, indicating that they are on the right path by providing quality and innovative services that can address urgent healthcare access issues worldwide.”

Related Links:
Hilab


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Enterovirus Test
Quanty Enterovirus System
New
UHF RFID Tag & Inlay
AD-327 U9 ETSI Pure 95
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.